Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Arizona State Retirement System

Arizona State Retirement System lessened its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1.7% in the 4th quarter, HoldingsChannel reports. The fund owned 25,766 shares of the company’s stock after selling 439 shares during the period. Arizona State Retirement System’s holdings in Acadia Healthcare were worth $2,004,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ACHC. Headlands Technologies LLC acquired a new position in shares of Acadia Healthcare during the third quarter worth $25,000. Point72 Hong Kong Ltd acquired a new position in shares of Acadia Healthcare during the 1st quarter worth about $38,000. Fifth Third Bancorp increased its holdings in shares of Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares during the last quarter. Belpointe Asset Management LLC lifted its stake in Acadia Healthcare by 75.7% during the first quarter. Belpointe Asset Management LLC now owns 982 shares of the company’s stock worth $71,000 after purchasing an additional 423 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare in the third quarter valued at approximately $96,000.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $74.98 on Friday. The stock has a market capitalization of $6.92 billion, a PE ratio of -299.91, a price-to-earnings-growth ratio of 2.23 and a beta of 1.31. Acadia Healthcare Company, Inc. has a 52-week low of $66.49 and a 52-week high of $87.77. The stock’s 50-day moving average price is $80.24 and its 200 day moving average price is $77.49. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. During the same quarter in the previous year, the firm posted $0.70 EPS. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.

Insiders Place Their Bets

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ACHC. Stephens upgraded shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price for the company in a report on Friday, January 5th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. TD Cowen boosted their target price on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Barclays assumed coverage on Acadia Healthcare in a report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 target price for the company. Finally, TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Hold” and an average target price of $91.22.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.